stopping glp 1 cold turkey What Happens If You Stop GLP-1 (30-Day Timeline) Stopping GLP-1 drugs can quickly

A new study uncovered an association between glucagon-like peptide-1 receptor agonist (GLP-1RAs) use and an increased risk of gastroparesis (GP) among patients with Type 2 diabetes.

The latest data shows where the agency is focusing and what companies should be preparing for now.

Our team reviews Maximus Tribe to see if it's your best bet for TRT and at-home testosterone testing.

Link to full post: GLP-1 Drugs, Digital Health & Obesity Trends in 2026Overweight and obesity are driving a booming digital health market through telehealth, wearables, and new pharma-to-consumer models.I've been reporting on this space in my #Trends report since March 2024two years ago (Navigating Obesity Care in the Digital Age)

By Vital Nutrients

How Payer Friction and Patient Drop-Off Undermine Obesity GLP-1 Uptake The GLP-1 market is experiencing unprecedented demand, yet despite its clinical promise for obesity, diabetes, and other conditions, patient behavior and friction throughout the treatment journey continue to erode its commercial potential